ICES Central (Chu, Shah, Rashid, Booth, Sun, Abdel-Qadir, Tobe, Lee); University of Toronto (Chu, Shah, Booth, Fazli, Tu, Abdel-Qadir, Yu, Connelly, Tobe, Lee); Sunnybrook Health Sciences Centre (Shah, Tobe); Unity Health Toronto (Booth, Fazli, Yu, Connelly); University Health Network (Tu, Abdel-Qadir, Lee); North York General Hospital (Tu), Toronto, Ont.; University of Ottawa Heart Institute (Sun, Liu); University of Ottawa (Sun, Shin), Ottawa, Ont.; Woman's College Hospital (Abdel-Qadir); Keenan Research Centre (Connelly), Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ont.; Northern Ontario School of Medicine (Tobe), Sudbury, Ont.
CMAJ Open. 2022 Aug 23;10(3):E772-E780. doi: 10.9778/cmajo.20210195. Print 2022 Jul-Sep.
Early identification of people with diabetes or prediabetes enables greater opportunities for glycemic control and management strategies to prevent related complications. To identify gaps in screening for these conditions, we examined population trends in receipt of timely glucose testing overall and in specific clinical subgroups.
Using linked administrative databases, we conducted a retrospective cohort study of people aged 40 years and older without diabetes at baseline. Our primary outcome was up-to-date glucose testing, defined as having received testing at least once in the 3 years before each index year from 2010 to 2017, using linked administrative databases of people residing in Ontario, Canada. We calculated rates of up-to-date testing by age group, sex, ethnicity (South Asian, Chinese, general population) and comorbidities (hypertension, hyperlipidemia, cardiovascular disease).
Over the 8-year study period, up-to-date glucose testing rates were stable at 67% for men and 77% for women (both relative risk 1.00 per year; 95% confidence interval 1.00-1.00). Testing rates were significantly lower in men than in women (all age groups < 0.001) and lower in younger than older age groups (except those aged ≥ 80 yr). South Asian people had the highest testing rates, although among people aged 70 years or older, testing was highest in the general population ( < 0.001). Among people with hypertension, hyperlipidemia and cardiovascular disease, annual testing rates were also stable, but only 58% overall among people with hypertension.
We found lower glucose testing rates in younger men and people with hypertension. Our findings reinforce the need for initiatives to increase awareness of glycemic testing.
早期识别糖尿病或糖尿病前期患者,为血糖控制和管理策略提供了更多机会,以预防相关并发症。为了发现这些疾病筛查中的差距,我们检查了整体和特定临床亚组中及时进行葡萄糖检测的人群趋势。
我们使用链接的行政数据库,对基线时无糖尿病的 40 岁及以上人群进行了回顾性队列研究。我们的主要结局是最新的葡萄糖检测,定义为在 2010 年至 2017 年的每个索引年前的 3 年内至少接受过一次检测,使用居住在加拿大安大略省的人的链接行政数据库。我们按年龄组、性别、族裔(南亚裔、华裔、一般人群)和合并症(高血压、高血脂、心血管疾病)计算最新检测率。
在 8 年的研究期间,男性和女性的最新葡萄糖检测率分别稳定在 67%和 77%(相对风险每年 1.00;95%置信区间 1.00-1.00)。男性的检测率明显低于女性(所有年龄组均 < 0.001),年轻组的检测率低于老年组(≥ 80 岁除外)。南亚裔人群的检测率最高,尽管在 70 岁或以上的人群中,一般人群的检测率最高(< 0.001)。在高血压、高血脂和心血管疾病患者中,每年的检测率也保持稳定,但高血压患者的总体检测率仅为 58%。
我们发现年轻男性和高血压患者的葡萄糖检测率较低。我们的研究结果强调了需要开展提高血糖检测意识的举措。